Alzheimer’s Disease R&D Expenditure Snapshot 2019
Alzheimer’s drugs represent a high-risk, high-reward proposition for global pharma. As David H. Crean…
Facts
Top European Pharma Mid-Cap Ranking 2019
The European MidPharma Performance Ranking 2019 is taken from The Novasecta European Midpharma Report 2019, which…
Sweden Pharma R&D Snapshot
Over EUR 1 billion was spent in Sweden on pharmaceutical R&D in 2015, a similar level to spending seen in Italy…
Sweden Pharma Market Snapshot 2019
The size of the Swedish pharma market is dwarfed by those of the EU5, but Sweden does host the largest market in…
Taiwan Innovation Snapshot
As part of its ‘Asia Silicon Valley Development Plan’, Taiwan has designated a special focus to each of…
Sweden Health Profile
Cardiovascular diseases are the leading cause of death among both men and women in Sweden, followed by cancer and…
Top 100 Pharma Companies Shaping the Future of Healthcare (Novasecta)
A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma…
Top 10 Clinical CROs in Korea
Ten of the top contract research organizations (CROs) currently operating in South Korea, as selected by KoNECT,…
Top 10 Orphan Drugs in the USA
The Top 10 bestselling orphan drugs in the USA in 2017. Celgene’s Revlimid (generic name lenolidamide) leads…
Top 10 Global Orphan Drug Companies Ranking
The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants…
Orphan Drugs in the USA: A Snapshot
80 orphan drugs (those drugs intended to treat diseases so rare that sponsors are reluctant to develop them under…
Malaysia Pharma Market Snapshot
The growth of the Malaysian pharma market between 2006 and 2016. Pharmaceutical sales grew to over USD 2 billion by…